Navigation Links
Spherix Issues Reminder of Business Update Conference Call Set for Today at Noon Eastern Time
Date:11/16/2011

BETHESDA, Md., Nov. 16, 2011 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, is issuing the following reminder that Spherix management will host a conference call to provide a business update and answer questions today at 12:00 noon Eastern time.  The business update will cover study results from the past quarter, directions for the drug development program, and financial results.

To access the conference call, from the U.S. please dial (866) 322-1352 and from outside the U.S. please dial (706) 643-6246. All listeners should provide the following passcode 24848484.  Individuals interested in listening to the live conference call via the Internet may do so by logging on to the Company's website, www.spherix.com.

Following the end of the conference call, a telephone replay will be available until midnight November 22 and can be accessed by dialing (855) 859-2056 from the U.S. or (404) 537-3406 from outside of the U.S.  All listeners should provide the following passcode: 24848484. The webcast will be available for 30 days.

About Spherix

Spherix Incorporated was launched in 1967 as a scientific research company under the name Biospherics Research. The Company now leverages its scientific and technical expertise and experience through its two subsidiaries – Biospherics Incorporated and Spherix Consulting, Inc. Biospherics is dedicated to developing and licensing/marketing proprietary therapeutic products for treatment of diabetes, metabolic syndrome and atherosclerosis. Biospherics is actively seeking a pharmaceutical partner to continue the development of it
'/>"/>

SOURCE Spherix Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Spherix Reports Second Quarter Earnings
2. Growth Achieved in Spherixs Health Sciences Consulting Business
3. Spherix D-tagatose to be Supplied by Inalco SpA
4. Spherix Expands Phase 3 Naturlose Diabetes Trial Outside of the U.S.
5. Spherix Postpones 2009 Annual Shareholders Meeting to Share Interim Diabetes Clinical Trial Data
6. Spherix Elects New Independent Director, and Elects Chairman of the Board
7. Spherix Reports First Quarter 2009 Earnings
8. Spherix Announces Positive Phase 2 Study Results
9. Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes
10. Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco
11. Spherix Reports Third Quarter 2009 Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)...  In today,s ever-changing marketplace, call centers must meet ... connected, and increasingly impatient with slow service. The need ... and tools is driving call centers to explore new ... According to research by benchmarking firm, Best Practices, LLC, ... a call center study realize the impact of social ...
(Date:7/31/2015)... 2015 More than 1,500 substance abuse prevention ... in Indianapolis Aug. 2-6 for ... Training Institute . The week-long training, held at the ... of our nation,s biggest public health challenges – youth ... is a one-of-a-kind intensive training opportunity, offering more than ...
(Date:7/31/2015)... 31, 2015 RnRMarketResearch.com adds ... research report that provides an overview of syringes ... sourced from in-house databases, secondary and primary research. ... market products pipeline spread across 124 pages, talking ... tables and 5 figures is now available at ...
Breaking Medicine Technology:Best Practices in Building World-Class Consumer & Over-the-Counter Call Centers 2Community Leaders From Across The Country Head To Indianapolis For CADCA 2015 Mid-Year Training Institute Aug. 2-6 2Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 5
... display at Rockefeller Plaza this month will emphasize ... almost 250,000 people per day with this important ... Industry Foundation,s National Colorectal Cancer Research Alliance (EIF,s ... Prevention,s (CDC,s) Screen for Life: National Colorectal ...
... -- CK Life Sciences Int,l., (Holdings) Inc. ("CK Life Sciences" ... and Drug Administration) has granted clearance for its subsidiary Polynoma ... proceed with Phase III clinical testing of its melanoma vaccine. ... sian Companies Cleared by FDA for Phase III Clinical Trial ...
Cached Medicine Technology:EHE International Joins Forces With Entertainment Industry Foundation's National Colorectal Cancer Research Alliance and the CDC to Encourage Screening 2CK Life Sciences Announces U.S. FDA's Clearance to Commence Phase III Clinical Testing of Melanoma Vaccine 2CK Life Sciences Announces U.S. FDA's Clearance to Commence Phase III Clinical Testing of Melanoma Vaccine 3
(Date:8/1/2015)... ... August 01, 2015 , ... Calvary Hospital today announced ... at their Bronx campus. The goal is to bring this Torah – dating from ... in Jewish rituals and religious services. , Scroll No. 515, from the town ...
(Date:8/1/2015)... ... August 01, 2015 , ... On Tuesday, July 28th, Symantec released a security ... have been behind the attack on Anthem Inc. which resulted in one of the ... hole attacks and spear phishing campaigns. , For Joe Caruso, founder and ...
(Date:8/1/2015)... , ... August 01, 2015 , ... On March 19, 2015 Phil Valentine – the ... of the Appalachian Trail by stepping off Springer Mountain and heading north. Since ... July 26th Phil reached Connecticut and was greeted by friends and family. He visited ...
(Date:7/31/2015)... ... August 01, 2015 , ... The Honor Society of ... Panel on the Future of Nursing (GAPFON) 20-21 July 2015 in San Juan, Puerto ... in this meeting. , Dr. Silvia Cassiani, Advisor, Nursing and Allied Health Personnel Development, ...
(Date:7/31/2015)... Atlanta, GA (PRWEB) , ... July 31, 2015 ... ... the five new industry players to know in predictive health analytics , ... machine learning technologies. The firm creates predictive software that targets patient and population ...
Breaking Medicine News(10 mins):Health News:Calvary Hospital Announces Plans to Restore Historic Torah 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2
... 6 CareMedic Systems ( ... comprehensive solution for managing patient financial data, has entered into ... ( http://www.cincom.com ), for its Cincom ... entire revenue cycle. , , Registration-based data-quality issues ...
... recurrence, investigators say , MONDAY, July 6 (HealthDay News) ... signals that help breast cancer cells survive in the bone ... in the July issue of the journal Cancer Cell ... return, according to the researchers. , "We sought to identify ...
... causes of disorder should now include celiac disease, study suggests, ... who have autoimmune diseases such as type 1 diabetes, ... times greater risk for autism, a new study finds. , ... type 1 diabetes and rheumatoid arthritis had been found in ...
... year as many as seven million adults in the ... review of the scientific literature on delirium prevention and ... Regenstrief Institute and Wishard Health Services found that despite ... hospitalized adults, no effective way to prevent or treat ...
... In a study to determine the non-medical factors that ... breast cancer, researchers at Columbia University Mailman School of ... the receipt of chemotherapy in elderly women with breast ... receive chemotherapy if treated by oncologists employed in a ...
... , IRVINE, Calif., July 6 Quest International, Inc. announced ... Healthcare,s Best Global Supplier of the Year Award. This ... presented with the award, receiving honors in 2006 as well. ... 2009 Siemens Annual Supplier Conference. Quest was selected for ...
Cached Medicine News:Health News:CareMedic and Cincom Sign OEM Technology Partnership for Healthcare Solution 2Health News:Research Reveals Clues to Breast Cancer's Spread 2Health News:Autism May Be Linked to Mom's Autoimmune Disease 2Health News:Autism May Be Linked to Mom's Autoimmune Disease 3Health News:Autism May Be Linked to Mom's Autoimmune Disease 4Health News:Delirium in hospitalized adults: Situation critical, no relief available 2Health News:Elderly breast cancer patients receive chemotherapy if treated in private practices 2Health News:Elderly breast cancer patients receive chemotherapy if treated in private practices 3Health News:Quest International Repeats Win as Siemens Healthcare Best Global Supplier of the Year 2Health News:Quest International Repeats Win as Siemens Healthcare Best Global Supplier of the Year 3
Inquire...
... A revolutionary new agar plate for economically ... of this biplate with the urine specimen. If ... on the chromogenic side of the biplate will ... are E. coli, the BluEcoli™ Urine Biplate is ...
The Onar®Lp test system is an in vitro test for the qualitative diagnosis of legionella in clinical samples....
... Trinity Biotech Captia™ Legionella pneumophila ... is intended for the qualitative ... and IgM) to Legionella pneumophila ... from patients with clinical suspicion ...
Medicine Products: